Stock MBX MICROBIX BIOSYSTEMS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Microbix Biosystems Inc.

Equities

MBX

CA59501P1045

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 03:59:47 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.325 CAD -2.99% Intraday chart for Microbix Biosystems Inc. -4.41% -16.67%
Apr. 25 Microbix to Present New Lab Accreditation Program at European Congress on Clinical Microbiology MT
Mar. 27 Transcript : Microbix Biosystems Inc. - Shareholder/Analyst Call

Valuation

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 17.56 21.24 62 51.23 30.76 32.62 - -
Enterprise Value (EV) 1 17.56 21.24 62 51.23 30.76 32.62 32.62 32.62
P/E ratio - - 22.5 x 39.2 x - 16.3 x 16.3 x 8.13 x
Yield - - - - - - - -
Capitalization / Revenue - 2.57 x 4.28 x 3.66 x 2.48 x 1.75 x 1.53 x 1.13 x
EV / Revenue - 2.57 x 4.28 x 3.66 x 2.48 x 1.75 x 1.53 x 1.13 x
EV / EBITDA - -30.3 x 14.1 x 19.1 x -26 x 10.8 x 8.67 x 4.61 x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 96,973 108,773 124,849 138,991 137,009 137,417 - -
Reference price 2 0.2400 0.2600 0.6300 0.5100 0.3050 0.3250 0.3250 0.3250
Announcement Date 12/20/19 12/18/20 12/23/21 12/22/22 12/21/23 - - -
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - 8.274 14.48 14 12.42 18.59 21.32 28.77
EBITDA 1 - -0.7002 4.405 2.677 -1.184 3.025 3.762 7.082
EBIT - - - - - - - -
Operating Margin - - - - - - - -
Earnings before Tax (EBT) - - 2.517 1.37 - - - -
Net income 0.0242 - 2.517 1.309 - - - -
Net margin - - 17.39% 9.35% - - - -
EPS 2 - - 0.0280 0.0130 - 0.0200 0.0200 0.0400
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 12/20/19 12/18/20 12/23/21 12/22/22 12/21/23 - - -
1USD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: September 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 4.383 3.832 3.748 3.926 3.178 1.862 3.128 4.127 3.207 6.203 3.762 3.984 4.574
EBITDA 1 1.407 1.063 0.9177 0.8412 0.0251 -0.7151 0.3154 -0.2704 -0.5109 2.178 0.074 0.221 0.516
EBIT - - - - - - - - - - - - -
Operating Margin - - - - - - - - - - - - -
Earnings before Tax (EBT) 0.6064 0.695 0.5633 0.5006 - -0.9669 0.0234 - - - - - -
Net income 0.6064 0.695 0.5633 0.5003 - -0.9669 0.0234 - - - - - -
Net margin 13.84% 18.14% 15.03% 12.74% - -51.93% 0.75% - - - - - -
EPS 0.006000 0.006000 0.005000 0.004000 -0.003000 -0.009000 - -0.006000 0.0140 - - - -
Dividend per Share - - - - - - - - - - - - -
Announcement Date 12/23/21 2/10/22 5/12/22 8/11/22 12/22/22 2/9/23 5/11/23 8/10/23 12/21/23 2/14/24 - - -
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - - - - - - -
Capex / Sales - - - - - - - -
Announcement Date 12/20/19 12/18/20 12/23/21 12/22/22 12/21/23 - - -
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.325 CAD
Average target price
0.8 CAD
Spread / Average Target
+146.15%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
MICROBIX BIOSYSTEMS INC. Stock Microbix Biosystems Inc.
-16.67% 32.62M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. MBX Stock
  4. Financials Microbix Biosystems Inc.